NYCRIS logo - click to reload menu
Taxanes Audit Lung Audit Thyroid Audit Prostate Audit Audit Projects

The use of Radical Therapy for
Patients with Non-Small Cell Lung Cancer

Copyright NYCRIS 2001. Extracts from these pages may be reproduced provided the source is fully acknowledged.   Return to AUDIT PROJECTS.

Lung Audit Report
20 Dec 2003 Executive Report
20 Dec 2003 - Extended Literature Review
20 Dec 2001 - Guidelines Review
20 Dec 2003 - Additional Analyses (Appendices)
20 Dec 2003 - Evaluation Form (to fax or send back)

Calendar of Events
04 Jul 2003 - Steering Group Meeting - Agenda - Notes
10 Dec 2001 - Steering Group Meeting - Agenda - Notes - Analysis
10 Jan 2001 - Steering Group Meeting - Agenda - Notes - Presentation1 2
09 Jun 2000 - Protocol Development Group Meeting - Agenda - Notes
11 Feb 2000 - Protocol Development Group Meeting - Agenda - Notes

20 Aug 2003 - Acknowledgements - NYCRIS Staff & Steering Group  
25 Feb 2001 - Data Collection Proforma  (final)
10 Jan 2001 - Protocol  (final draft)


The current audit is a retrospective review of the use of radical radiotherapy (conventional) and surgery (lobectomy and pneumonectomy), for NSCLC patients and the criteria and assessments used in selecting appropriate patients around the region.

The rationale agreed at the start of the project is given below.

Clinical guidelines for the management of lung cancer have recently been published by several organisations. These recommend that every effort should be made to identify lung cancer patients who may have the chance of long-term survival if they are offered radical treatment. The guidelines specify that full staging and assessment are necessary for patients who might be considered for radical treatment, including a computed tomography (CT) scan followed by mediastinoscopy if CT findings are unclear.

Surgery has been considered by some to be the only curative treatment for non small cell lung cancer, even though very few patients with this diagnosis are suitable for surgery. For patients undergoing surgery, neoadjuvant or adjuvant treatment with chemotherapy or radiotherapy is recommended only in the context of a clinical trial. However, postoperative radiotherapy may also be employed.

top of page